ZIM
IDXX icon

Zacks Investment Management’s Idexx Laboratories IDXX Stock Holding History

Zacks Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-526
Closed -$256K – 724
2024
Q2 		$256K Sell
526
-6,418
-92% -$3.22M ﹤0.01% 539
2024
Q1 		$3.75M Buy
6,944
+1,029
+17% +$562K 0.04% 233
2023
Q4 		$3.28M Sell
5,915
-533
-8% -$250K 0.04% 233
2023
Q3 		$2.82M Sell
6,448
-849
-12% -$423K 0.04% 231
2023
Q2 		$3.66M Sell
7,297
-13,919
-66% -$6.67M 0.05% 211
2023
Q1 		$10.6M Buy
+21,216
New +$10.2M 0.14% 137
2022
Q1 		– Sell
-5,812
Closed -$3.83M – 620
2021
Q4 		$3.83M Sell
5,812
-10,001
-63% -$6.28M 0.05% 221
2021
Q3 		$9.83M Buy
15,813
+859
+6% +$577K 0.16% 135
2021
Q2 		$9.45M Sell
14,954
-1,345
-8% -$743K 0.15% 130
2021
Q1 		$7.98M Buy
16,299
+937
+6% +$469K 0.14% 137
2020
Q4 		$7.68M Buy
15,362
+873
+6% +$391K 0.14% 133
2020
Q3 		$5.7M Buy
14,489
+8,113
+127% +$3M 0.12% 138
2020
Q2 		$2.1M Buy
6,376
+125
+2% +$36.2K 0.05% 193
2020
Q1 		$1.51M Sell
6,251
-71
-1% -$18.5K 0.04% 232
2019
Q4 		$1.65M Sell
6,322
-1,357
-18% -$358K 0.03% 304
2019
Q3 		$2.09M Buy
7,679
+358
+5% +$99.6K 0.04% 244
2019
Q2 		$2.02M Sell
7,321
-10
-0.1% -$2.46K 0.04% 263
2019
Q1 		$1.64M Buy
7,331
+360
+5% +$74.3K 0.04% 294
2018
Q4 		$1.3M Sell
6,971
-226
-3% -$46.3K 0.03% 300
2018
Q3 		$1.8M Sell
7,197
-168
-2% -$40.8K 0.04% 298
2018
Q2 		$1.6M Buy
7,365
+418
+6% +$86.1K 0.03% 325
2018
Q1 		$1.33M Sell
6,947
-106
-2% -$19.6K 0.03% 360
2017
Q4 		$1.1M Buy
7,053
+1,037
+17% +$163K 0.02% 384
2017
Q3 		$935K Sell
6,016
-661
-10% -$105K 0.02% 387
2017
Q2 		$1.08M Buy
6,677
+1,123
+20% +$182K 0.03% 352
2017
Q1 		$859K Buy
+5,554
New +$766K 0.02% 397
2016
Q4 		– Sell
-11,254
Closed -$1.27M – 678
2016
Q3 		$1.27M Buy
+11,254
New +$1.19M 0.04% 281

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Zacks Investment Management's IDXX Position: Q3 2024 in Review

Zacks Investment Management sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 526 shares — an estimated $256K sold.

Zacks Investment Management first reported a position in IDXX in Q3 2016 and held it in 27 quarters. The position peaked at $10.6M in Q1 2023. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

  • Zacks Investment Management reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
  • Zacks Investment Management sold 526 Idexx Laboratories shares in Q3 2024, an estimated $256K.
  • Zacks Investment Management first reported a position in Idexx Laboratories in Q3 2016 and held it in 27 quarters.
  • Zacks Investment Management's Idexx Laboratories position peaked at $10.6M in Q1 2023.
  • 1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Zacks Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.